AI Article Synopsis
- - The first implantation of the Tricento transcatheter heart valve was successfully performed on a 74-year-old woman with severe tricuspid regurgitation using a minimally invasive method through the femoral vein.
- - After the procedure, the valve significantly reduced the volume of regurgitant blood flow in the caval veins, leading to both symptomatic and clinical improvement after three months.
- - The Tricento device offers a new treatment option for patients suffering from severe tricuspid regurgitation who are unable to undergo traditional open-heart surgery.
Article Abstract
Here we describe the first implantation of the novel bicavally anchored Tricento transcatheter heart valve via the transvenous transfemoral access in a 74-year-old woman with severe tricuspid regurgitation and holosystolic hepatic vein backflow. Following successful implantation, caval vein regurgitant volume was reduced leading to symptomatic and clinical improvement at three-month follow-up. The Tricento device represents a promising, novel therapeutic option for patients with severe tricuspid regurgitation who are not candidates for open heart surgery.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.4244/EIJ-D-18-00440 | DOI Listing |
Publication Analysis
Top Keywords
severe tricuspid
12
tricuspid regurgitation
12
tricento transcatheter
8
transcatheter heart
8
heart valve
8
first-in-man implantation
4
implantation tricento
4
valve treatment
4
treatment severe
4
regurgitation describe
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!